In line with what was already validated for AD, Nasca et al. reported an increased number of EXOs enriched for L1 cell adhesion molecules (L1CAM, predominantly expressed in the brain) in subjects with MDD, which, in turn, were enriched for the insulin receptor substrate-1 (IRS-1) [113]. Here, IRS1 is linked to Alzheimer disease.